AbbVie

YTD

ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Robert A. Michael

CEORobert A. Michael

Employees

55,000

Employees55,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

55,000

Employees55,000

ABBV Key Statistics

Market cap

338.24B

Market cap338.24B

Price-Earnings ratio

80.80

Price-Earnings ratio80.80

Dividend yield

3.37%

Dividend yield3.37%

Average volume

5.14M

Average volume5.14M

High today

$192.72

High today$192.72

Low today

$189.06

Low today$189.06

Open price

$189.34

Open price$189.34

Volume

3.91M

Volume3.91M

52 Week high

$218.66

52 Week high$218.66

52 Week low

$163.52

52 Week low$163.52

ABBV News

Seeking Alpha 5d

AbbVie continues gains for seven straight sessions

AbbVie (NYSE:ABBV) continued gains for seven straight sessions, as the stock closed 1.3% higher at $189.90 on Friday. The North Chicago-based pharma giant gain...

The Motley Fool 7d

Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks

Some stock-trading platforms enable their users to automatically replicate the positions taken by experienced investors or other famous figures. Many investors...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

40%

Sell

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.